ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 295501 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 295501; 2) Community: the network communities that were significantly associated with the response to NSC 295501; 3) Molecule: the relationships between components within communities and NSC 295501; 4) MDR: the compounds that were significantly associated with the NSC 295501.

NSC Compound Enrichment Correlation
NSC 642913 Null 0.00180188182321727 0.52605625
NSC 645431 1H-Benz[g]indol-5-ol, 2-phenyl 0.00180188182321727 0.18313217
NSC 689140 1H,3H-Benzo[c]pyrrolo[3,4-a]carbazole-1,3-dione, 2,3a,3b,4,5,6,7,7a-octahydro-2-(4-methoxyphenyl)- 9-methyl-5-phenyl- 0.00180188182321727 0.30739306
NSC 107124 Camptothecin Derivative 0.00182957917645006 0.75368212
NSC 343499 CI-921: amsacrine derivative 0.00182957917645007 0.77927522
NSC 639364 2,9-Dimethylellipticinium acetate 0.00182957917645007 0.1703399
NSC 641225 Null 0.00182957917645007 0.39689083
NSC 648365 Insulin-Methotrexate conjugate 0.00182957917645007 0.63996955
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.00182957917645007 0.59393017
NSC 657676 Null 0.00182957917645007 0.23117288
Total:58  Current:4    [First] [Prev] [Next] [Last]